These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6810900)

  • 21. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
    J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
    Tominaga T; Yoshida Y; Shimozuma K; Hayashi K; Kosaki G
    Eur J Cancer; 1990; 26(5):600-3. PubMed ID: 2144748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of aromatase inhibition on luteinizing hormone secretion in intact and castrated male cynomolgus macaques.
    Resko JA; Connolly PB; Roselli CE; Abdelgadir SE; Choate JV
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1529-34. PubMed ID: 8263136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer.
    Koibuchi Y; Sugamata N; Iino Y; Yokoe T; Andoh T; Maemura M; Takei H; Horiguchi J; Matsumoto H; Morishita Y
    Int J Mol Med; 1999 Aug; 4(2):145-8. PubMed ID: 10402480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Iino Y; Sugamata N; Owada S; Tago T; Sato H; Yokoe T; Maemura M; Morishita Y; Horiuchi R
    Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sugamata N; Koibuchi Y; Iino Y; Morishita Y
    Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
    Zaccheo T; Di Salle E
    Cancer Chemother Pharmacol; 1989; 25(2):95-8. PubMed ID: 2513137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of the aromatase inhibitor FCE 24928 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
    Zaccheo T; di Salle E
    Cancer Chemother Pharmacol; 1993; 31(4):308-12. PubMed ID: 8422695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
    Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of the aromatase inhibitor delta 1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease.
    Dunaif A; Longcope C; Canick J; Badger T; Crowley WF
    J Clin Endocrinol Metab; 1985 Apr; 60(4):773-80. PubMed ID: 3919053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal inhibition of aromatase activity affects luteinizing hormone feedback mechanisms and reproductive behaviors of adult guinea pigs.
    Choate JV; Resko JA
    Biol Reprod; 1994 Dec; 51(6):1273-8. PubMed ID: 7888505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of aromatase inhibitors and different doses of testosterone on gonadotropins in one year old male Atlantic salmon (Salmo salar).
    Antonopoulou E; Swanson P; Borg B
    Comp Biochem Physiol A Mol Integr Physiol; 2009 Aug; 153(4):408-16. PubMed ID: 19345741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW; Ip C; Ip MM
    Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Breast Cancer Res Treat; 1993; 26(1):15-21. PubMed ID: 8400320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Steroids; 1987; 50(1-3):135-46. PubMed ID: 3504057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
    Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
    Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
    Luo S; Sourla A; Labrie C; Bélanger A; Labrie F
    Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aromatase inhibitors prevent granulosa cell differentiation: an obligatory role for estrogens in luteinizing hormone receptor expression.
    Knecht M; Brodie AM; Catt KJ
    Endocrinology; 1985 Sep; 117(3):1156-61. PubMed ID: 2990868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumor.
    Houjou T; Wada T; Yasutomi M
    Clin Ther; 1993; 15(1):137-47. PubMed ID: 8458043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.